The guideline provides pragmatic, evidence-based, easy-to-implement recommendations and streamlined algorithms.

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be ...

Understand Peripheral Artery Disease (PAD) and its link with hypertension. Learn about the causes, symptoms, and risks ...

Minimally invasive adrenalectomy can safely improve secondary hypertension in patients with unilateral adrenal incidentalomas ...

Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that ...

Patients with worse glaucoma severity were more likely to experience steroid-induced ocular hypertension, according to a ...

Salina Family Healthcare Center to leverage Rimidi’s RPM solution in support of its work with the Million Hearts® initiative ...

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

Intensive blood pressure management may lower the risk of developing dementia or cognitive impairment without dementia.

The pulmonary arterial hypertension (PAH) drug preserved its safety profile at 2.5 years of treatment and continued to reduce ...